Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Donna L. Gutterman"'
Autor:
Terence J, O'Brien, Samuel F, Berkovic, Jacqueline A, French, John A, Messenheimer, Terri B, Sebree, Marcel O, Bonn-Miller, Donna L, Gutterman, Fredrik, Asztely
Publikováno v:
JAMA network open. 5(7)
ImportanceCannabidiol has shown efficacy in randomized clinical trials for drug-resistant epilepsy in specific syndromes that predominantly affect children. However, high-level evidence for the efficacy and safety of cannabidiol in the most common fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::061fb059c5c8023c4f00f107fec11912
https://pubmed.ncbi.nlm.nih.gov/36515958
https://pubmed.ncbi.nlm.nih.gov/36515958
Autor:
Donna L. Gutterman, Roger Cady, Stephen O'Quinn, Richard B. Lipton, Walter F. Stewart, Charles B. Hall
Publikováno v:
Headache: The Journal of Head and Face Pain. 40:792-797
Objective.—To evaluate the effectiveness of sumatriptan, 50-mg tablets, versus placebo for early intervention while head pain was mild in patients with disabling migraine. Methods.—A post hoc analysis was performed in a subgroup of patients from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::710c519fd4f31d3bac7d1247086b9664
https://doi.org/10.1046/j.1526-4610.2000.00144.x
https://doi.org/10.1046/j.1526-4610.2000.00144.x
Autor:
Stephen O'Quinn, Richard B. Lipton, Donna L. Gutterman, Roger Cady, Walter F. Stewart, Timothy Kuhn, Charles B. Hall
Publikováno v:
Headache: The Journal of Head and Face Pain. 40:783-791
Background.—Migraineurs experience a spectrum of headaches: migraine, migrainous, and episodic tension-type as defined by the International Headache Society (IHS). Objective.—To evaluate the effectiveness of sumatriptan, 50-mg tablets, in treatin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7227a4f324d85a2394de84881d79a1e5
https://doi.org/10.1046/j.1526-4610.2000.00143.x
https://doi.org/10.1046/j.1526-4610.2000.00143.x
Publikováno v:
Cephalalgia. 19:668-675
Polypharmacy (the prescription of more than one therapy for a single patient) and subcutaneous (s.c.) sumatriptan tolerability were prospectively studied in 12,339 migraineurs, each followed for up to 1 year. Inclusion/exclusion criteria were minimal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9e397ce6afb231637975ce65f1f9984
https://doi.org/10.1046/j.1468-2982.1999.019007668.x
https://doi.org/10.1046/j.1468-2982.1999.019007668.x
Publikováno v:
Clinical Therapeutics. 18:687-699
The efficacy and tolerability of subcutaneous (SC) sumatriptan administered with the IMITREX (sumatriptan succinate) STATdose System, which circumvents the need for patients or health care professionals to handle a syringe, were evaluated in two rand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::223270ef546ef40834cb59078032e94e
https://doi.org/10.1016/s0149-2918(96)80219-0
https://doi.org/10.1016/s0149-2918(96)80219-0
Autor:
Jane Saiers, Paul E. Stang, Donna L. Gutterman, Anthony W. Fox, Randall Weeks, Alan M. Rapoport, Herbert G. Markley, Roger Cady
Publikováno v:
Headache: The Journal of Head and Face Pain. 36:14-19
Background: Frequent, excessive use of over-the-counter or prescription analgesics may lead to analgesic rebound headache. Little is known about the magnitude of the health problem posed by analgesic rebound headache, its epidemiology, the characteri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a08b17bd070498b606898240b587cbb0
https://doi.org/10.1046/j.1526-4610.1996.3601014.x
https://doi.org/10.1046/j.1526-4610.1996.3601014.x
Publikováno v:
PharmacoEconomics. 2:67-76
Migraine headache is responsible for significantly more healthcare resource and lost labour costs than previously reported. Costs associated with migraine were assessed via a survey conducted in 940 patients, 70% of whom responded. All met the Intern
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38258885c4f08fb3f06a429223aa3722
https://doi.org/10.2165/00019053-199202010-00008
https://doi.org/10.2165/00019053-199202010-00008
Autor:
Randy Davis, Donna L. Gutterman, Sara A. Ephross, Stephen O'Quinn, Anthony W. Fox, Vanessa C. Williams
Publikováno v:
Archives of gynecology and obstetrics. 263(1-2)
Background: Sumatriptan is an acute treatment for migraine which is often used by women in their child-bearing years, and who become unexpectedly pregnant. Within the context of the post-marketing use of sumatriptan injection for the acute treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60491522ccc53928d20f7d93722b6f5c
https://pubmed.ncbi.nlm.nih.gov/10728620
https://pubmed.ncbi.nlm.nih.gov/10728620
Publikováno v:
Cephalalgia : an international journal of headache. 19(4)
To investigate prospectively serious adverse events associated with sumatriptan injection, we studied 12,339 typical migraineurs for up to 12 months each. This study imitated the ordinary clinical use of sumatriptan injection except that: (a) a short
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d5299f1965d719ef203039564ce3ebd
https://pubmed.ncbi.nlm.nih.gov/10376167
https://pubmed.ncbi.nlm.nih.gov/10376167
Publikováno v:
Cephalalgia : an international journal of headache. 17(5)
In a long-term efficacy and satiety study, 424 patients were treated with sumatriptan (6 mg sc) for 1,904 migraine attacks. The patients were diagnosed with migraine based on IHS criteria but individual migraine attacks treated in the study were phys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e1929530889f7096b112ed21352871c
https://pubmed.ncbi.nlm.nih.gov/9251874
https://pubmed.ncbi.nlm.nih.gov/9251874